GLP-1 receptor agonists
‘I just don’t understand it’
Longtime pharmacy owner and dietitian queries direct-to-consumer model for weight loss medicines NSW pharmacist and dietitian John Jones has expressed concerns over the recent launch of LillyDirect, Eli Lilly’s platform …
‘Possible’ GLP-1 effects in substance use disorders
Despite “lots of interest” in possible reductions in alcohol and smoking, cost and side effects may present barriers to using popular weight loss drugs in addiction medicine Major studies have …
TGA issues new guidance on compounding
New compounding guidance outlines restrictions and expectations for “higher risk” products including GLP-1s and medicinal cannabis Pharmacists are being urged to review new guidance from the Therapeutic Goods Administration (TGA) to …
PBAC accused of ‘lack of ambition’
Manufacturers of GLP-1 medications are stepping up pressure on the federal government to subsidise their products for weight loss Sponsors of glucagon-like peptide-1 (GLP-1) medications are accusing the Pharmaceutical Benefits Advisory Committee …
Cost ‘major barrier’ to access, patients lowering doses
Resounding support for subsidising GLP-1s for obesity treatment, PBS public consultation submissions show, with quality of medicines issues present Submissions from 491 consumers, 25 health professionals and 23 organisations to …
Weight loss drugs added to WADA’s watchlist
GLP-1s could be added to the World Anti-Doping Agency’s prohibited list before the 2028 Olympics Over the next two years, the World Anti-Doping Agency (WADA) is set to review whether use of glucagon-like peptide-1 medications gives …
TGA issues fake GLP-1 warning
Testing confirms imported unregistered GLP-1 weight loss products are not what they claim to be Consumers are being urged to avoid purchasing online medicines claiming to contain glucagon-like peptide-1s (GLP-1s), warning …
‘Concerning’: Low levels of contraception alongside GLP-1 use
Off-label use of GLP-1s among women of reproductive age has skyrocketed since 2020, with researchers concerned about its potential impact on unintended pregnancies Community pharmacists have an opportunity to counsel …
Inquiry backs expansion of GLP-1 RA eligibility
Government urged to make Glucagon-like Peptide-1 receptor agonists (GLP-1 RAs) available to more patients Steps to improve access to GLP-1 RAs for high-risk patients are among 23 recommendations in the …